Star Therapeutics to present VGA039 trial data at ISTH 2026

June 26, 2026 9:00 AM

Star Therapeutics announced it will present complete safety and efficacy data from its Phase 1/2 multidose study of VGA039, an ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found